Recombinant Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase (pr)

What is 6-pyruvoyl tetrahydrobiopterin synthase in Drosophila melanogaster?

6-pyruvoyl tetrahydrobiopterin synthase in Drosophila melanogaster is an enzyme encoded by the purple (pr) gene that plays a crucial role in the biosynthesis of pteridine eye pigments and tetrahydrobiopterin. This enzyme catalyzes the second step in the de novo biosynthesis pathway of tetrahydrobiopterin, specifically converting dihydroneopterin triphosphate to 6-pyruvoyl tetrahydropterin. The full-length protein consists of 168 amino acids and belongs to the PTPS family . According to the search results, the enzyme has an Enzyme Commission designation of 4.2.3.12, indicating its role as a lyase acting on carbon-nitrogen bonds . Its function is required for both pigment and biopterin synthesis in Drosophila .

What is the role of this enzyme in the tetrahydrobiopterin synthesis pathway?

This enzyme catalyzes a critical step in the de novo biosynthesis pathway of tetrahydrobiopterin (BH4), which is an essential cofactor for various cellular processes. Specifically, it converts dihydroneopterin triphosphate (H2-NTP) to 6-pyruvoyl tetrahydropterin (PPH4) . This reaction follows the initial step catalyzed by GTP cyclohydrolase I (GTPCH), which converts GTP to H2-NTP. After 6-pyruvoyl tetrahydrobiopterin synthase action, the pathway continues with sepiapterin reductase (SR) converting PPH4 to tetrahydrobiopterin . The entire pathway involves a complex series of reactions, and the enzyme-catalyzed reaction includes triphosphate elimination, stereospecific reduction of the N5-C6 double bond, and oxidation of both side-chain hydroxyl groups .

How is the purple gene related to this enzyme in Drosophila?

The purple (pr) gene in Drosophila melanogaster encodes the 6-pyruvoyl tetrahydrobiopterin synthase enzyme. This gene was initially identified as one of the target loci of the suppressor mutation su(sj2) . Mutations in the purple gene lead to altered eye pigmentation in Drosophila, specifically causing a purple eye color phenotype, which is how the gene got its name. The connection between the purple gene and 6-pyruvoyl tetrahydrobiopterin synthase function was established when researchers cloned the cDNA encoding this enzyme and demonstrated its enzymatic activity in converting dihydroneopterin triphosphate to 6-pyruvoyl tetrahydropterin . The purple gene product is essential for both pigment and biopterin synthesis in Drosophila, highlighting its dual role in both visual and metabolic functions .

What alternative names are used for this enzyme in scientific literature?

The 6-pyruvoyl tetrahydrobiopterin synthase enzyme in Drosophila melanogaster is known by several alternative names in the scientific literature and databases. According to the search results, these include:

In database entries, the protein can be found under identifiers such as KEGG: Dmel_CG16784, STRING: 7227.FBpp0088417, and UniGene: Dm.476 .

Which expression systems have been used for recombinant production?

Several expression systems have been employed for the recombinant production of Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase:

• Escherichia coli: The cDNA has been expressed as fusion proteins in E. coli. This bacterial expression system allows for high-yield production and has been used to create recombinant proteins for enzyme characterization studies. In one study, the recombinant protein was purified from E. coli crude extract using metal-chelation chromatography, and the fused metal-chelating oligopeptide was removed by thrombin for further characterization .

• Yeast: According to the product details from CD BioSciences Drosophila Center, recombinant 6-pyruvoyl tetrahydrobiopterin synthase is also produced in yeast expression systems . This eukaryotic expression platform may provide advantages for proper protein folding and post-translational modifications.

The choice of expression system depends on the research goals, with bacterial systems offering high yield and simplicity, while yeast systems might provide more native-like protein structures for certain applications.

What are the biochemical properties of the recombinant enzyme?

Recombinant Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase exhibits several distinct biochemical properties that have been characterized through experimental studies:

Kinetic Parameters:

• The apparent Km for the substrate dihydroneopterin triphosphate is approximately 590 μM, which is slightly higher than the value observed for the native enzyme .

Physical Properties:

• Molecular Weight: The subunit molecular weight is 19.3 kDa

• Isoelectric Point: The recombinant enzyme has an isoelectric point of 6.4, which differs from the native enzyme's value of 4.3

Enzyme Stability and Activation:

• Heat Stability: Similar to the native enzyme

• Reducing Agents: Shows stimulatory effects in the presence of reducing agents, comparable to the native enzyme

• Cysteine Modification: Modification of cysteine residues by iodoacetamide inhibits activity by up to 80%, indicating the importance of these residues for catalysis

Enzymatic Reaction:

• The enzyme catalyzes a Zn and Mg-dependent reaction

• The reaction includes triphosphate elimination, stereospecific reduction of the N5-C6 double bond, and the oxidation of both side-chain hydroxyl groups

The full-length recombinant protein contains 168 amino acids with the sequence provided in the product information .

How does the structure of this enzyme contribute to its function?

The crystal structure of 6-pyruvoyl tetrahydrobiopterin synthase provides valuable insights into how the enzyme's structure facilitates its catalytic function:

Active Site Components:

• The active site consists of a pterin-anchoring Glu A107 residue

• Two critical catalytic motifs: a Zn(II) binding site and an intersubunit catalytic triad

• The catalytic triad is formed by Cys A42, Asp B88, and His B89, spanning across two different subunits of the enzyme

Zinc Coordination:

• In the free enzyme, the Zn(II) ion is in tetravalent coordination with three histidine ligands and a water molecule

• In the substrate-bound complex, the water is replaced by the two substrate side-chain hydroxyl groups, yielding a penta-coordinated Zn(II) ion

Catalytic Mechanism:

• The Zn(II) ion plays multiple crucial roles: it activates the protons of the substrate, stabilizes reaction intermediates, and prevents unwanted bond breaking in the pyruvoyl side-chain

• Cys A42 is activated by His B89 and Asp B88, enabling it to abstract protons from different substrate side-chain atoms (C1' and C2')

• This structural arrangement allows the enzyme to perform proton abstractions from two different side-chain carbon atoms with no obvious preference

The structure of the enzyme is optimized to position the substrate correctly for catalysis, with the metal ion and the catalytic triad working in concert to facilitate the complex reaction. The intersubunit nature of the catalytic triad also explains why the enzyme functions as an oligomer rather than as a monomer.

What is the detailed catalytic mechanism of this enzyme?

The catalytic mechanism of Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase involves several sophisticated chemical transformations coordinated by specific structural elements of the enzyme:

• Substrate Binding:

  • Dihydroneopterin triphosphate (H2-NTP) binds to the active site with its pterin moiety anchored by Glu A107

  • The side-chain hydroxyl groups of the substrate coordinate with the Zn(II) ion, displacing a water molecule and creating a penta-coordinated metal center

• Triphosphate Elimination:

  • The enzyme catalyzes the elimination of the triphosphate group from H2-NTP

  • Kinetic studies with dihydroneopterin monophosphate indicate that the triphosphate moiety is necessary for enzyme specificity

• Redox Transformations:

  • The reaction involves a stereospecific reduction of the N5-C6 double bond

  • Simultaneously, both side-chain hydroxyl groups undergo oxidation

  • These redox changes are coordinated by the Zn(II) ion, which activates the substrate protons

• Proton Abstraction:

  • Cys A42, activated by the His B89 and Asp B88 catalytic triad, abstracts protons from the C1' and C2' substrate side-chain atoms

  • Modeling studies suggest that both C1' and C2' substrate side-chain protons are at equal distances to Cys A42 Sγ, explaining the enzyme's ability to abstract protons from both positions

• Product Formation:

  • The final product, 6-pyruvoyl tetrahydropterin (PPH4), is formed after these multiple transformations

  • PPH4 can be further converted to tetrahydrobiopterin by sepiapterin reductase in the presence of NADPH

This catalytic mechanism highlights the role of the enzyme as a multifunctional catalyst that performs both elimination and redox chemistry in a single active site, with the metal ion and catalytic residues precisely positioned to facilitate these transformations.

How do mutations in the active site affect enzyme activity?

Mutations in the 6-pyruvoyl tetrahydrobiopterin synthase active site can significantly affect enzyme activity, providing insights into the catalytic mechanism and the importance of specific residues:

Cysteine Mutations:

• The inactive mutant Cys42Ala has been crystallized and studied, demonstrating the critical role of Cys42 in catalysis

• When Cys42 is replaced with alanine, the enzyme loses its ability to abstract protons from the substrate, rendering it catalytically inactive

• Modification of cysteine residues with iodoacetamide inhibits activity by up to 80%, further confirming their importance

Zinc-Binding Residues:

• Alterations to the histidine residues that coordinate the Zn(II) ion would be expected to disrupt metal binding and severely impair catalysis

• The Zn(II) ion is essential for substrate activation and stabilization of reaction intermediates

Catalytic Triad Components:

• Since the catalytic triad (Cys A42, Asp B88, His B89) spans two different subunits, mutations in any of these residues can affect the proton abstraction capability of the enzyme

• The basicity of Cys A42 is enhanced by His B89 and Asp B88, so mutations in these residues would reduce the nucleophilicity of the cysteine

Pterin-Anchoring Residue:

• Mutations in Glu A107, which anchors the pterin moiety of the substrate, would likely affect substrate binding and orientation

These structure-function relationships are valuable for understanding enzyme mechanisms and potentially for designing inhibitors or enhanced variants of the enzyme for research purposes. The crystal structure of the Cys42Ala mutant in complex with the substrate has provided particularly valuable insights into the spatial arrangement of the active site and the roles of specific residues .

What are the differences between Drosophila and homologous enzymes from other species?

Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase shares similarities with homologous enzymes from other species but also exhibits notable differences:

Sequence Conservation:

• Complete sequences for 6-pyruvoyl tetrahydrobiopterin synthase enzymes are available from several mammals and Drosophila, with partial sequences known from salmon

• The enzymes share conserved regions, particularly around the active site and metal-binding regions

• One of the cysteine residues in Drosophila 6-pyruvoyl tetrahydrobiopterin synthase is known to be conserved in human and rat enzymes, indicating functional significance

Biochemical Properties:

• The isoelectric point of Drosophila recombinant enzyme (6.4) differs from the native enzyme (4.3), suggesting post-translational modifications

• The Km value for dihydroneopterin triphosphate in Drosophila 6-pyruvoyl tetrahydrobiopterin synthase (590 μM) may differ from those of homologous enzymes in other species

Physiological Context:

• In Drosophila, the enzyme is involved in the synthesis of pteridine eye pigments, a function not present in mammals

• In both Drosophila and mammals, the enzyme participates in tetrahydrobiopterin synthesis, which serves as a cofactor for various enzymes

Fungal Comparison:

• In Mortierella alpina, a lipid-producing fungus, the BH4 biosynthetic pathway has been characterized and includes 6-pyruvoyl tetrahydrobiopterin synthase

• Unlike Drosophila, which has one GTP cyclohydrolase I (the enzyme preceding 6-pyruvoyl tetrahydrobiopterin synthase in the pathway), M. alpina has two functional GTP cyclohydrolase I enzymes, reflecting its unique ability to synthesize both BH4 and folate

Understanding these cross-species differences is valuable for comparative biochemistry and for inferring the evolutionary history of this essential metabolic pathway.

How can the recombinant enzyme be optimized for experimental studies?

Optimizing recombinant Drosophila melanogaster 6-pyruvoyl tetrahydrobiopterin synthase for experimental studies involves several considerations to enhance expression, purification, stability, and activity:

Expression System Selection:

• Both E. coli and yeast expression systems have been used successfully

• E. coli offers high yield and simplicity but may lack some post-translational modifications

• Yeast systems may provide more native-like protein folding and modifications

• The choice depends on the specific research requirements and downstream applications

Fusion Tags and Purification:

• According to the product details, N-terminal His-tagged and tag-free versions are available

• Metal-chelation chromatography has been used effectively for purification of His-tagged enzyme

• For activity studies, the fusion tag can be removed using thrombin, as described in the research

Buffer and Storage Optimization:

• The recombinant protein is typically stored in Tris/PBS-based buffer with 6% trehalose at pH 8.0

• For long-term storage, addition of 5-50% glycerol and storage at -20°C/-80°C is recommended

• Lyophilized powder has a longer shelf life (12 months) compared to liquid form (6 months)

Reconstitution Protocol:

• Brief centrifugation of the vial before opening is recommended

• Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Addition of glycerol for aliquoting and long-term storage

Activity Enhancement:

• Based on the research findings, reducing agents have a stimulatory effect on enzyme activity

• Avoiding modification of cysteine residues is crucial as iodoacetamide treatment inhibits activity

• Ensuring the presence of zinc ions in assay buffers is important for optimal activity

These optimization strategies can help researchers maximize the utility of recombinant 6-pyruvoyl tetrahydrobiopterin synthase in their experimental work, whether for structural studies, enzyme kinetics, or screening of potential modulators.

What experimental approaches are used to measure enzyme activity in vitro?

Several experimental approaches are employed to measure 6-pyruvoyl tetrahydrobiopterin synthase activity in vitro, each with specific advantages and applications:

Spectrophotometric Assays:

• Monitoring the ultraviolet absorption spectrum of reaction products

• The conversion of dihydroneopterin triphosphate to 6-pyruvoyl-tetrahydropterin results in characteristic spectral changes that can be measured

• This approach allows real-time monitoring of enzyme activity

HPLC Analysis:

• High-performance liquid chromatography can separate and quantify reaction products

• This method provides high sensitivity and specificity for detecting 6-pyruvoyl-tetrahydropterin and other pterins

• HPLC coupled with electrospray ionization-mass spectrometry (ESI-MS) has been used for definitive identification of reaction products

Coupled Enzyme Assays:

• Enzyme activity can be measured in a coupled assay with downstream enzymes such as sepiapterin reductase

• The formation of final products like tetrahydrobiopterin or intermediates like 6-lactoyl-tetrahydropterin can be monitored

• NADPH consumption can be measured spectrophotometrically when coupled with sepiapterin reductase activity

Activity Indicators:

• Conversion of the product 6-pyruvoyl-tetrahydropterin to 6-lactoyl-tetrahydropterin in the presence of another enzyme (Enzyme B) and NADPH

• Further conversion to 5,6,7,8-tetrahydrobiopterin using biopterin synthase and NADPH

• Oxidation of enzymatically-produced 6-lactoyl-tetrahydropterin to sepiapterin when exposed to air

Kinetic Parameter Determination:

• Varying substrate concentrations to determine Km and Vmax values

• Inhibition studies using compounds like iodoacetamide to assess the importance of specific residues

• Assessing the effects of cofactors, metal ions, and reducing agents on enzyme activity

These methodologies provide complementary information about enzyme activity and mechanism, allowing researchers to characterize the enzyme comprehensively and investigate factors that influence its function.

How does this enzyme interact with other enzymes in the tetrahydrobiopterin synthesis pathway?

6-pyruvoyl tetrahydrobiopterin synthase functions as part of an integrated metabolic pathway for tetrahydrobiopterin (BH4) synthesis, interacting with several other enzymes:

Sequential Enzymatic Cascade:

• The enzyme catalyzes the second step in the de novo BH4 biosynthesis pathway

• It processes the output from GTP cyclohydrolase I (GTPCH), which converts GTP to dihydroneopterin triphosphate (H2-NTP)

• The product of the enzyme, 6-pyruvoyl tetrahydropterin (PPH4), serves as the substrate for sepiapterin reductase (SR)

Metabolic Channeling:

• Evidence suggests that intermediate products in the pathway may be channeled between enzymes

• This channeling would minimize the release of unstable intermediates and enhance pathway efficiency

• The physical proximity or potential protein-protein interactions between the enzyme and other pathway enzymes may facilitate this process

Regulatory Interactions:

• In the liver, BH4 levels regulate GTPCH I activity through feedback inhibition

• Phenylalanine can stimulate GTPCH I through the GTP cyclohydrolase I feedback regulatory protein

• These regulatory mechanisms affect the supply of substrate to 6-pyruvoyl tetrahydrobiopterin synthase, indirectly influencing its activity

Alternative Pathways:

Pathway in Different Species:

• In Mortierella alpina, a lipid-producing fungus, the pathway includes two copies of GTPCH (preceding 6-pyruvoyl tetrahydrobiopterin synthase), which is unusual and reflects the fungus's ability to synthesize both BH4 and folate

• Understanding these species-specific pathway differences provides insights into the evolutionary adaptations of this metabolic network

The coordinated action of 6-pyruvoyl tetrahydrobiopterin synthase with other enzymes in the BH4 synthesis pathway ensures the efficient production of this essential cofactor for various physiological processes.

What are the current challenges in studying enzyme function in Drosophila models?

Researchers face several challenges when studying 6-pyruvoyl tetrahydrobiopterin synthase function in Drosophila models:

Genetic Complexity:

• The purple (pr) gene interacts with suppressor mutations like su(sj2), complicating genetic analyses

• Understanding the interplay between the enzyme and other genes involved in pigment synthesis requires sophisticated genetic approaches

• Experimental evolution with Drosophila can be used to study adaptation, but requires careful control of selection protocols and population parameters

Biochemical Stability:

• Intermediates in the BH4 synthesis pathway, including the product of the enzyme, can be unstable

• This instability makes it challenging to isolate and characterize these compounds from biological samples

• Specialized techniques are needed to preserve and detect these labile metabolites

Multiple Physiological Roles:

• The enzyme is involved in both eye pigment synthesis and BH4 production, which serves as a cofactor for various enzymes

• Disentangling these dual functions when studying phenotypes of mutations can be difficult

• The interplay between visual pigmentation and metabolic functions mediated by BH4 adds complexity

Technical Limitations:

• Measuring enzyme activity in vivo requires sensitive and specific assays

• Distinguishing between effects on the enzyme itself and upstream or downstream enzymes in the pathway

• Creating tissue-specific and conditional mutations to study its function in different contexts

Translational Challenges:

• While Drosophila 6-pyruvoyl tetrahydrobiopterin synthase shares similarities with mammalian orthologs, there are also significant differences

• Extrapolating findings from Drosophila to human enzyme-related disorders requires careful consideration of these differences

• The unique aspects of pteridine metabolism in insects versus vertebrates must be accounted for

Emerging genomic technologies offer new opportunities to address these challenges. As mentioned in the search results, experimental evolution strategies combined with genomic tools can provide insights into both the evolution of physiological traits and the correlations between physiological and life history traits , which could be applied to understanding 6-pyruvoyl tetrahydrobiopterin synthase function in broader biological contexts.